A vaccine to treat prostate cancer came one step closer to approval last week, when an advisory panel to the US Food and Drug Administration said the product was safe and effective.
The panel recommended the FDA approve Provenge (sipuleucel-T), ...
More Information
The panel recommended the FDA approve Provenge (sipuleucel-T), ...
More Information